Cascadian Therapeutics, Inc. of SEATTLE, WA filed a SC14D9C with the SEC on 2018-01-31. Industry: Services-Commercial Physical & Biological Research.
| Seq | Type | Description |
|---|---|---|
| 1 | SC14D9C | SC14D9C |
| 2 | EX-99.1 | EX-99.1 |
| 3 | EX-99.2 | EX-99.2 |
| 4 | EX-99.3 | EX-99.3 |
| 5 | EX-99.4 | EX-99.4 |
| 6 | EX-99.5 | EX-99.5 |
| 7 | EX-99.6 | EX-99.6 |
| 8 | GRAPHIC | GRAPHIC |
| 9 | GRAPHIC | GRAPHIC |
| 10 | GRAPHIC | GRAPHIC |
| 11 | GRAPHIC | GRAPHIC |
| 12 | GRAPHIC | GRAPHIC |
| 13 | GRAPHIC | GRAPHIC |
| 14 | GRAPHIC | GRAPHIC |
| 15 | GRAPHIC | GRAPHIC |
Showing 12 of 41 filings.
| Filed | Form |
|---|---|
| 2018-03-09 | SC 14D9/A |
| 2018-02-26 | SC 14D9/A |
| 2018-02-16 | SC 14D9/A |
| 2018-02-14 | SC 14D9/A |
| 2018-02-08 | SC 14D9 |
| 2018-01-31 | SC14D9C |
| 2017-04-26 | DEFA14A |
| 2017-04-26 | DEF 14A |
| 2017-04-14 | PRE 14A |
| 2016-10-14 | DEF 14A |
| 2016-10-04 | DEFA14A |
| 2016-10-04 | PRE 14A |